Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
Devonian and Histapharm announced they have signed a binding LOI to negotiate the terms establishing Devonian as the exclusive site for manufacturing of Histapharm’s proprietary botanical drug.
read more
HitGen has entered into a drug discovery research collaboration with Gilead Sciences to identify potential small molecule leads against targets of interest to Gilead.
read more
Beam Therapeutics and Bio Palette today announced an exclusive cross-license agreement around each companies’ base editing intellectual property.
read more
Brazil's National Health Surveillance Agency has qualified Axis Biotec manufacturing facility in Rio de Janeiro to register, import, manufacture and also store and distribute biologic drugs in Brazil.
read more
Iovance Biotherapeutics has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU).
read more
Evidera has entered into an agreement to acquire Medimix International, a technology company providing RWE insights and information to the pharmaceutical, diagnostic and medical device industries.
read more
Lantheus Holdings has entered into an agreement with NanoMab Technology, a biopharmaceutical company focusing on the development of next generation radiopharmaceuticals to be used in the development of immuno-oncology therapies.
read more
CAPS® held a ribbon cutting ceremony for its new sterile compounding outsourcing facility in Phoenix, AZ, bringing nearly 400 jobs to the area.
read more
The opioid tragedy has become one of the defining public health crises of modern times.
read more
Lotus Clinical Research has announced the addition of Lee Simon, MD, FACP, FACR as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD, JD as Medical Imaging and Research Advisor.
read more
Clinipace has hired four operational, therapeutic, and medical experts to bolster the company’s global strategic development capabilities and medical expertise.
read more
Lumos Diagnostics and RPS Diagnostics announced they have merged. The combined company will be called Lumos Diagnostics.
read more
ReForm Biologics announced the appointment of Alan Herman, Ph.D. and Fred Larimore, Ph.D. to the company’s Scientific Advisory Board (SAB).
read more
Zymeworks has earned a milestone payment from Merck achieved under the companies’ 2014 research and license agreement.
read more